Search

everythinglearnresearchcommunity

for

Search:↓

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

The study found potential new DNA patterns in fertility genes, but further testing is needed.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Anabolic steroids and inflammation can disrupt androgen metabolism, potentially causing health issues.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Neurosteroids help control dopamine responses in the brain.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

ESR2 gene variations may be linked to female pattern hair loss.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.